🚀 VC round data is live in beta, check it out!
- Public Comps
- Azenta
Azenta Valuation Multiples
Discover revenue and EBITDA valuation multiples for Azenta and similar public comparables like Eckert & Ziegler, Vazyme Biotech, CareDx, Daan Gene and more.
Azenta Overview
About Azenta
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
Founded
1978
HQ

Employees
3.0K
Website
Financials (LTM)
EV
$798M
Azenta Financials
Azenta reported last 12-month revenue of $610M and EBITDA of $76M.
In the same LTM period, Azenta generated $281M in gross profit, $76M in EBITDA, and $30M in net income.
Revenue (LTM)
Azenta P&L
In the most recent fiscal year, Azenta reported revenue of $594M and EBITDA of $66M.
Azenta expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $610M | XXX | $594M | XXX | XXX | XXX |
| Gross Profit | $281M | XXX | $270M | XXX | XXX | XXX |
| Gross Margin | 46% | XXX | 46% | XXX | XXX | XXX |
| EBITDA | $76M | XXX | $66M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | $30M | XXX | $23M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 4% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Azenta Stock Performance
Azenta has current market cap of $1B, and enterprise value of $798M.
Market Cap Evolution
Azenta's stock price is $25.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $798M | $1B | 0.0% | XXX | XXX | XXX | $0.51 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAzenta Valuation Multiples
Azenta trades at 1.3x EV/Revenue multiple, and 10.6x EV/EBITDA.
EV / Revenue (LTM)
Azenta Financial Valuation Multiples
As of April 20, 2026, Azenta has market cap of $1B and EV of $798M.
Equity research analysts estimate Azenta's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Azenta has a P/E ratio of 38.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $798M | XXX | $798M | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | 10.6x | XXX | 12.1x | XXX | XXX | XXX |
| EV/EBIT | 31.9x | XXX | 49.4x | XXX | XXX | XXX |
| EV/Gross Profit | 2.8x | XXX | 3.0x | XXX | XXX | XXX |
| P/E | 38.0x | XXX | 49.2x | XXX | XXX | XXX |
| EV/FCF | 18.5x | XXX | 20.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Azenta Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Azenta Margins & Growth Rates
Azenta's revenue in the last 12 month grew by 6%.
Azenta's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Azenta's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Azenta's rule of X is 27% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Azenta Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 26% | XXX | 26% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 27% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 5% | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 49% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Azenta Public Comps
See public comps and valuation multiples for other Laboratory Services and Diagnostics & Genomics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Azenta | XXX | XXX | XXX | XXX | XXX | XXX |
| Eckert & Ziegler | XXX | XXX | XXX | XXX | XXX | XXX |
| Vazyme Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| CareDx | XXX | XXX | XXX | XXX | XXX | XXX |
| Daan Gene | XXX | XXX | XXX | XXX | XXX | XXX |
| NeoGenomics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Azenta M&A Activity
Azenta acquired XXX companies to date.
Last acquisition by Azenta was on XXXXXXXX, XXXXX. Azenta acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Azenta
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAzenta Investment Activity
Azenta invested in XXX companies to date.
Azenta made its latest investment on XXXXXXXX, XXXXX. Azenta invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Azenta
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Azenta
| When was Azenta founded? | Azenta was founded in 1978. |
| Where is Azenta headquartered? | Azenta is headquartered in United States. |
| How many employees does Azenta have? | As of today, Azenta has over 3K employees. |
| Who is the CEO of Azenta? | Azenta's CEO is John P. Marotta. |
| Is Azenta publicly listed? | Yes, Azenta is a public company listed on Nasdaq. |
| What is the stock symbol of Azenta? | Azenta trades under AZTA ticker. |
| When did Azenta go public? | Azenta went public in 1995. |
| Who are competitors of Azenta? | Azenta main competitors are Eckert & Ziegler, Vazyme Biotech, CareDx, Daan Gene. |
| What is the current market cap of Azenta? | Azenta's current market cap is $1B. |
| What is the current revenue of Azenta? | Azenta's last 12 months revenue is $610M. |
| What is the current revenue growth of Azenta? | Azenta revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Azenta? | Current revenue multiple of Azenta is 1.3x. |
| Is Azenta profitable? | Yes, Azenta is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Azenta? | Azenta's last 12 months EBITDA is $76M. |
| What is Azenta's EBITDA margin? | Azenta's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Azenta? | Current EBITDA multiple of Azenta is 10.6x. |
| What is the current FCF of Azenta? | Azenta's last 12 months FCF is $43M. |
| What is Azenta's FCF margin? | Azenta's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Azenta? | Current FCF multiple of Azenta is 18.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.